Today: 9 June 2026
Dow Jones Rises Past 50,000 Again After Closing Bell
20 May 2026
2 mins read

Dow Jones Rises Past 50,000 Again After Closing Bell

New York, May 20, 2026, 16:03 (EDT)

  • Dow Jones Industrial Average closed above 50,000 again after giving up ground Tuesday.
  • Chip stocks bounced, with Nvidia earnings hopes bringing risk appetite back.
  • Stocks caught a break as oil prices and Treasury yields dropped, though Fed-rate worries lingered.

Dow tops 50,000 again as stocks bounce back The Dow Jones Industrial Average closed at 50,005.30 on Wednesday, up 1.30%, after sliding for three sessions on worries about inflation and bonds. The blue chips had ended at 49,363.88 the day before. In the session, the Dow traded as high as 50,013.62, according to market data.

Dow moved up and crossed a key level traders track, but tech stocks drove most of the action. The S&P 500 ended at 7,427.89. The Nasdaq Composite, with its heavier tech mix, finished at 26,219.01.

The Dow is price-weighted, so stocks with higher share prices move the index more than cheaper ones, no matter the company’s market cap. S&P Dow Jones Indices calls it a barometer of 30 U.S. blue-chips, focused on large firms outside of transportation and utilities.

Tech stocks pulled Wall Street higher. Nvidia gained ahead of its earnings, which are expected after the bell. The Philadelphia SE Semiconductor Index jumped 3.9%. Astera Labs and Arm Holdings led chip stocks up. Carol Schleif, chief market strategist at BMO Private Wealth, told Reuters, technology was “driving the bus” and said there was “clearly a lot of optimism.” Reuters

Nvidia was the next big test. Options traders had priced in a move of around 6.5% in the shares after earnings, according to Reuters on Tuesday. That implies about a $355 billion swing in market value. Matt Amberson, founder of ORATS, said investors looked “complacent about AI/capex,” his term for artificial intelligence spending and capital expenditures like data centers and chips. Reuters

The yield on the 10-year Treasury dropped to 4.57% from 4.67% late Tuesday, according to AP. Oil pulled back, with Brent crude down 5.3% to $105.36 a barrel after some of its war-related gains faded. Lower yields and cheaper oil can ease pressure on stocks by reducing borrowing costs and inflation. The backdrop was supportive.

Still, the rally faced pressure from rates. Minutes from the Federal Reserve showed most policymakers saw “some policy firming would likely become appropriate” if inflation stayed over the Fed’s 2% target. Ryan Sweet, chief global economist at Oxford Economics, said it will be a “difficult task anytime soon” to reach agreement on moving rates either way. Reuters

The trade can shift fast. A weak Nvidia outlook, higher oil, or rising Treasury yields could all shake Wednesday’s rebound. The Dow went back over 50,000, showing buyers are ready, but the inflation worry is still around.

Consumer stocks struggled. Target dropped after it warned about a difficult macro environment. Walmart was down ahead of its results. The action pointed to the ongoing tech-driven rally, with gains coming from relief on rates and not a wider consumer surge.

So the Dow crossed that after-bell level. The question now is if Nvidia or the Fed give anyone a reason to stay long up here.

Stock Market Today

  • Jim Cramer's Top 10 Market Watch Points for June 9
    June 9, 2026, 9:57 AM EDT. Jim Cramer's top 10 things to watch on June 9 include U.S. stocks rebounding after a selloff, supported by lower oil prices and bond yields. The SpaceX IPO is heavily oversubscribed, expected to start trading Friday, while OpenAI filed confidentially for its IPO with a potential trillion-dollar valuation. Anthropic secured a $35 billion debt deal to fund its AI growth. TD Cowen raised its Alphabet price target to $475 amid margin optimism, despite dilution concerns. Amazon issued a $10 billion Canadian dollar bond, the largest in that currency. China plans to invest $295 billion in AI data centers over five years. Micron is expected to beat earnings guidance, while Apple shares face pressure despite AI enhancements. GSK's $10.6 billion acquisition of Nuvalent lifts shares, highlighting moves in the healthcare sector.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Norwegian Cruise Line Gains 9% as Oil Drops, Fuel Still in Focus
Previous Story

Norwegian Cruise Line Gains 9% as Oil Drops, Fuel Still in Focus

RBC Stock Tops 52-Week High Ahead of May 28
Next Story

RBC Stock Tops 52-Week High Ahead of May 28

Go toTop